23 results
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
of the EMBRAVE study of elsunersen were presented at the American Epilepsy Society 2023 Annual Meeting, showing 43% median reduction in seizures; received … Epilepsies: At the American Epilepsy Society 2023 Annual Meeting, Praxis shared data from Part 1 of the EMBRAVE study, where four patients were dosed
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
27 Apr 22
Regulation FD Disclosure
4:34pm
as the Chief Medical/Innovation Officer of the Epilepsy Foundation. Past president of the American Epilepsy Society; past Secretary of the American … Society of Experimental Neurotherapeutics. Recipient of the American Epilepsy Society Lennox Award (2017) and Service Award (2005), the Epilepsy
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
28 Feb 22
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
6:06am
, PRAX-562 and its KCNT1 inhibitor, at the American Epilepsy Society 2021 Annual Meeting. Presentations on PRAX-562 focused on its potent anticonvulsant
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
11 May 21
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2021 Financial Results
8:11am
clinical trials through appropriate study design and conduct.
Preclinical and clinical data for PRAX-114 was presented at the Society of Biological
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
9 Nov 22
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:03pm
in the International Parkinson and Movement Disorder Society (MDS) Unified Parkinson’s Disease Rating Scale (UPDRS) Part III (motor examination) score
8-K
EX-99.1
rr44px9g4t18 orj1ee
28 Nov 22
Regulation FD Disclosure
8:04am
424B4
vpwjlexj2oay g1rl1ox
14 May 21
Prospectus supplement with pricing info
4:34pm
S-3ASR
8zgvhmlu
3 Nov 21
Automatic shelf registration
5:08pm
DRS
ejwnu5
18 Mar 21
Draft registration statement
12:00am
10-K
zxsb66y5pgxgg7m73
17 Mar 21
Annual report
8:33am
DRS
gukm8u vfrhyg37vc7
22 Jul 20
Draft registration statement
12:00am
424B4
mx83zr04
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1
abkwyna2azqdrt
25 Sep 20
IPO registration
5:19pm
DRS/A
k8pzy543b r7o2bx82
28 Aug 20
Draft registration statement (amended)
12:00am